This inventor holds 4 USPTO granted patents. Top assignees: Iqvia Inc., Quintiles Transnational Corporation. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: Innovations of Donald R Harder
Introduction
Donald R Harder is an accomplished inventor based in Fishers, IN (US). He holds a total of 4 patents that contribute significantly to the field of clinical planning and design. His work focuses on enhancing the efficiency and effectiveness of clinical trials through innovative methods and systems.
Latest Patents
One of his latest patents is titled "Methods and systems for predictive clinical planning and design." This patent outlines a method that includes instantiating a plurality of data objects, each containing clinical trial information. The method involves displaying a graphical user interface on one or more screens, which provides a graphical representation of a clinical trial with multiple graphical nodes. It also details the process of receiving a selection of a graphical node, modifying the associated data object, and propagating the modification to ensure accurate clinical trial data representation.
Career Highlights
Throughout his career, Donald R Harder has worked with notable companies such as Quintiles Transnational Corporation and IQVIA Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to clinical planning.
Collaborations
Donald has collaborated with several professionals in his field, including Daniel D Siders and Leslie Thomas. These collaborations have contributed to the advancement of his inventions and the successful implementation of his patented methods.
Conclusion
Donald R Harder is a notable inventor whose contributions to predictive clinical planning and design have made a significant impact in the field. His innovative methods and collaborations continue to shape the future of clinical trials.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
